TITLE

Onychomycosis Alternative

AUTHOR(S)
Hill, Suzette
PUB. DATE
May 2003
SOURCE
Dermatology Times;May2003, Vol. 24 Issue 5, p20
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Focuses on the use of clotrimazole lacquer formulated with the drug delivery technology CPE-215 for treating onychomycosis. Improvement of patients using clotrimazole lacquer.
ACCESSION #
9725346

 

Related Articles

  • White superficial onychomycosis.  // Journal of Cutaneous Medicine & Surgery;Sep/Oct2004, Vol. 8 Issue 5, p380 

    Discusses the abstract of the study "White Superficial Onychomycosis," by B.M. Piraccini and colleagues.

  • Study of onychomycosis. Vijaya, D.; Anandkumar, B.H.; Geetha, S.H. // Indian Journal of Dermatology, Venereology & Leprology;May/Jun2004, Vol. 70 Issue 3, p185 

    Cites key findings from several microbiology and dermatology experts' microbiological study of onychomycosis.

  • Treating Onychomycosis. Rodgers, Phillip; Bassler, Mary // American Family Physician;2/15/2001, Vol. 63 Issue 4, p663 

    Onychomycosis accounts for one third of fungal skin infections. Because only about one half of nail dystrophies are caused by fungus, the diagnosis should be confirmed by potassium hydroxide preparation, culture or histology before treatment is started. Newer, more effective antifungal agents...

  • Review: Oral antifungal therapy has low risk for adverse events in superficial dermatophytosis and onychomycosis.  // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p14 

    The article presents a study which examines the safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis. Here, the researcher use a randomized controlled trial. Study shows that oral antifungal therapy has low risk for adverse events in patients with superficial...

  • COMMENTARY: Review: Oral antifungal therapy has low risk for adverse events in superficial dermatophytosis and onychomycosis. Shear, Neil H. // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p14 

    The author comments on the study which examines the safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis. According to the author, the results in the study are not true for tinea corporis, hyperkeratoric tinea pedis, and foot onychomytosis, where oral antifungal...

  • Search for biological control agents against Candida yeasts and other dermatomycetes. Melvydas, V.; Šakalytė, J.; Paškevičius, A.; Gedminienė, G. // Biologija;2007, Issue 1, p45 

    The objective of this work was to screen the killer action of the bacterial isolates T1x, T2x, T3x, Ux and Ux308 against some dermatomycetes and the genus Candida yeast. The bacterial isolates T1x, T2x, T3x, Ux were recovered from spontaneous fruit and berry fermentations and the Ux308 isolate...

  • Onychomycosis in two geographically distinct regions in India. Gurung, Shrijana; Yegneshwaran, Prakash Peralam; Bhutia, Pema Yoden; Gupta, Amlan; Bairy, Indira; Pradhan, Jagat; Pradhan, Uttam; Sharma, Dhruva; Peggy, Tshering // Archives of Clinical Microbiology;2012, Vol. 3 Issue 6, p1 

    Background: Onychomycosis is worldwide in distribution and the genera of causative agents are diverse. This study was carried out to demonstrate if the causative agents differed with a difference in temperature, climate and locale. Methods: Seventy patients in coastal tropical region of...

  • Potential of Ravuconazole and its Prodrugs as the New Oral Therapeutics for Onychomycosis. Hideyo Yamaguchi // Medical Mycology Journal;2016, Vol. 57 Issue 4, pE93 

    Onychomycosis is a fungal infection of the nail apparatus caused by dermatophytes, Candida and nondermatophytic molds. It is highly prevalent in the general population worldwide and also responsible for significant morbidity and complications and does not usually cure itself. Thus, the condition...

  • Treatment of Onychomycosis in Diabetic Patients. Winston, Jason A.; Miller, Jami L. // Clinical Diabetes;Fall2006, Vol. 24 Issue 4, p160 

    Onychomycosis is more common in diabetic than nondiabetic patients. It is more than a cosmetic problem, and diabetic patients have a greater risk of serious complications from the disease, including limb amputations. This article reviews the various diagnostic and therapeutic options available...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics